½ÃÀ庸°í¼­
»óǰÄÚµå
1442884

´ÜÀ§ ¾à¹° Åõ¿© ½Ã½ºÅÛ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)

Unit Drug Dose Delivery System Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Transparency Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 202 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

´ÜÀ§ ¾à¹° Åõ¿© ½Ã½ºÅÛ ½ÃÀå - º¸°í¼­ÀÇ ¹üÀ§

¼¼°è ´ÜÀ§ ¾à¹° Åõ¿© ½Ã½ºÅÛ ½ÃÀå¿¡ ´ëÇÑ TMRÀÇ º¸°í¼­´Â °ú°Å¿Í ÇöÀçÀÇ ¼ºÀå µ¿Çâ°ú 2024³âºÎÅÍ 2032³â±îÁöÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ÁöÇ¥¿¡ ´ëÇÑ ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ´Â ±âȸ¸¦ ¿¬±¸Çϰí ÀÖ½À´Ï´Ù. ÀÌ º¸°í¼­´Â 2024³âÀ» ±âÁØ ¿¬µµ·Î, 2032³âÀ» ¿¹Ãø ¿¬µµ·Î °£ÁÖÇÏ¿© 2018³âºÎÅÍ 2032³â±îÁöÀÇ ±â°£ µ¿¾È ´ÜÀ§ ¾à¹° Åõ¿© ½Ã½ºÅÛ ½ÃÀåÀÇ ¼öÀÍÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ º¸°í¼­´Â ¶ÇÇÑ 2024³âºÎÅÍ 2032³â±îÁö ¼¼°è ´ÜÀ§ ¾à¹° Åõ¿© ½Ã½ºÅÛ ½ÃÀåÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR %)À» Á¦°øÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ±¤¹üÀ§ÇÑ Á¶»ç¸¦ ÅëÇØ ÀÛ¼ºµÇ¾ú½À´Ï´Ù. 1Â÷ Á¶»ç¿¡¼­´Â ÁÖ¿ä ¿ÀÇǴϾ𠸮´õ, ¾÷°è ¸®´õ, ¿ÀÇǴϾð ¸ÞÀÌÄ¿¸¦ ´ë»óÀ¸·Î ¾Ö³Î¸®½ºÆ®°¡ ÀÎÅͺäÇÏ´Â ¹æ½ÄÀ¸·Î ´ëºÎºÐÀÇ Á¶»ç Ȱµ¿ÀÌ ÀÌ·ç¾îÁ³½À´Ï´Ù. 2Â÷ Á¶»ç¿¡´Â ´ÜÀ§ ¾à¹° Åõ¿© ½Ã½ºÅÛ ½ÃÀåÀ» ÀÌÇØÇϱâ À§ÇØ ÁÖ¿ä ±â¾÷ÀÇ Á¦Ç° ¹®Çå, ¿¬·Ê º¸°í¼­, º¸µµ ÀÚ·á ¹× °ü·Ã ¹®¼­¿¡ ´ëÇÑ ÂüÁ¶°¡ Æ÷ÇԵ˴ϴÙ.

ÀÌ º¸°í¼­´Â ¼¼°è ´ÜÀ§ ¾à¹° Åõ¿© ½Ã½ºÅÛ ½ÃÀåÀÇ °æÀï ȯ°æ¿¡ ´ëÇØ ÀÚ¼¼È÷ Á¶»çÇϰí ÀÖ½À´Ï´Ù. ¼¼°è ´ÜÀ§ ¾à¹° Åõ¿© ½Ã½ºÅÛ ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÌ È®ÀεǾúÀ¸¸ç, ÀÌµé °¢°¢Àº ´Ù¾çÇÑ ¼Ó¼º Ãø¸é¿¡¼­ ÇÁ·ÎÆÄÀϸµµË´Ï´Ù. ȸ»ç ÇÁ·ÎÇÊ, À繫 »óÅÂ, ÃÖ±Ù µ¿Çâ ¹× SWOT´Â ÀÌ º¸°í¼­¿¡ ¼Ò°³µÈ ¼¼°è ´ÜÀ§ ¾à¹° Åõ¿© ½Ã½ºÅÛ ½ÃÀå ±â¾÷ÀÇ ¼Ó¼ºÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °üÁ¡

  • ½ÃÀå Á¤ÀÇ
  • ½ÃÀå ºÐ·ù¹ý

Á¦3Àå ½ÃÀå °³¿ä

  • ¼¼°èÀÇ Æ÷Àå ½ÃÀå °³¿ä
  • °Å½Ã°æÁ¦ ¿äÀÎ - »ó°ü ºÐ¼®
  • ¿¹Ãø¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
  • ½ÃÀå ¹ë·ùüÀÎ ºÐ¼®
  • ÄÉÀ̽º ±â¹Ý ½Ã³ª¸®¿À ¿µÇ⠺м®
  • ½ÃÀå ¿ªÇÐ

Á¦4Àå ½ÃÀå ºÐ¼®

  • °¡°Ý ºÐ¼®
    • °¡°Ý °¡Á¤
    • Áö¿ªº° °¡°Ý ¿¹Ãø
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ½ÃÀå ±Ô¸ð¿Í Àü³âºñ ¼ºÀå·ü
    • Àý´ëÀûÀÎ ±Ý¾× ±âȸ

Á¦5Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Àç·áº°

  • ¼Ò°³
    • ½ÃÀå Á¡À¯À²°ú º£À̽ýº Æ÷ÀÎÆ®(BPS) ºÐ¼® : Àç·áº°
    • Àü³âºñ ¼ºÀå·ü Àü¸Á : Àç·áº°
  • °ú°Å ½ÃÀå °¡Ä¡¿Í ¼ö·®(Åæ), 2018-2023³â : Àç·áº°
  • ½ÃÀå ±Ô¸ð¿Í ¼ö·®(Åæ) ¿¹Ãø ºÐ¼®, 2024-2032³â : Àç·áº°
    • ÇÃ¶ó½ºÆ½
      • Æú¸®ÇÁ·ÎÇÊ·»(PP)
      • Æú¸®¿¡Æ¿·»(PE)
        • HDPE
        • LDPE
      • Æú¸®¿¡Æ¿·» Å×·¹ÇÁÅ»·¹ÀÌÆ®(PET)
      • Æú¸®¿°È­ºñ´Ò(PVC)
      • Æú¸®½ºÆ¼·»
      • Æú¸®Ä«º¸³×ÀÌÆ®
    • À¯¸®
      • À¯Çü I
      • À¯Çü II
      • À¯Çü II
    • ±âŸ
  • ½ÃÀå ¸Å·Âµµ ºÐ¼® : Àç·áº°

Á¦6Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Æ÷Àå À¯Çüº°

  • ¼Ò°³
    • ½ÃÀå Á¡À¯À²°ú º£À̽ýº Æ÷ÀÎÆ®(BPS) ºÐ¼® : Æ÷Àå À¯Çüº°
    • Àü³âºñ ¼ºÀå ¿¹Ãø : Æ÷Àå À¯Çüº°
  • °ú°Å ½ÃÀå °¡Ä¡¿Í ¼ö·®(Åæ), 2018-2023³â : Æ÷Àå À¯Çüº°
  • ½ÃÀå ±Ô¸ð¿Í ¼ö·®(Åæ) ¿¹Ãø ºÐ¼®, 2024-2032³â : Æ÷Àå À¯Çüº°
    • ºí¸®½ºÅÍ Æ÷Àå
    • ÇÁ¸®ÇÊµå °¡´É ½Ã¸°Áö ¹× īƮ¸®Áö
    • ¹ÙÀ̾˰ú ¾ÚÇÃ
    • ±âŸ
  • ½ÃÀå ¸Å·Âµµ ºÐ¼® : Æ÷Àå À¯Çüº°
  • ÇöÀúÇÑ µ¿Çâ

Á¦7Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Á¦Ç° Çüź°

  • ¼Ò°³
    • ½ÃÀå Á¡À¯À²°ú º£À̽ýº Æ÷ÀÎÆ®(BPS) ºÐ¼® : Á¦Ç° Çüź°
    • Àü³âºñ ¼ºÀå ¿¹Ãø : Á¦Ç° Çüź°
  • °ú°Å ½ÃÀå °¡Ä¡¿Í ¼ö·®(Åæ), 2018-2023³â : Á¦Ç° Çüź°
  • ½ÃÀå ±Ô¸ð¿Í ¼ö·®(Åæ) ¿¹Ãø ºÐ¼®, 2024-2032³â : Á¦Ç° Çüź°
    • °íü
    • ¾×ü
    • ºÐ¸»
  • ½ÃÀå ¸Å·Âµµ ºÐ¼® : Á¦Ç° Çüź°

Á¦8Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°

  • ¼Ò°³
    • Áö¿ªº° ½ÃÀå Á¡À¯À²°ú º£À̽ýº Æ÷ÀÎÆ®(BPS) ºÐ¼®
    • Áö¿ªº° Àü³âºñ ¼ºÀå ¿¹Ãø
  • °ú°Å ½ÃÀå °¡Ä¡¿Í ¼ö·®(Åæ), 2018-2023³â : Áö¿ªº°
  • Áö¿ªº° ½ÃÀå ±Ô¸ð¿Í ¼ö·®(Åæ) ¿¹Ãø ºÐ¼®, 2024-2032³â
    • ºÏ¹Ì
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
  • Áö¿ªº° ½ÃÀå ¸Å·Â ºÐ¼®
  • ÇöÀúÇÑ µ¿Çâ

Á¦9Àå ºÏ¹Ì ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦11Àå À¯·´ ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦13Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦14Àå °æÀï »óȲ

  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±ÙÀÇ Àü°³, SWOT ºÐ¼®)
  • °æÀï »ó¼¼
    • Amcor plc
    • Wihuri Group
    • Schott AG
    • NIPRO
    • Gerresheimer AG
    • West Pharmaceutical Services, Inc.
    • SGD Pharma
    • R-Pharm Germany GmbH
    • Agrado SA
    • Constantia Flexibles
    • Stevanato Group
    • Klockner Pentaplast
    • Catalent, Inc.
    • Huhtamaki Oyj
    • Omnicell, Inc.
    • Piramal Enterprises Ltd.
    • O. Berk Company

Á¦15Àå »ç¿ëµÈ °¡Á¤°ú ¾à¾î

Á¦16Àå Á¶»ç ¹æ¹ý

KSM 24.04.18

Unit Drug Dose Delivery System Market - Scope of Report

TMR's report on the global unit drug dose delivery system market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2032. The report provides revenue of the global unit drug dose delivery system market for the period 2018-2032, considering 2024 as the base year and 2032 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global unit drug dose delivery system market from 2024 to 2032.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the unit drug dose delivery system market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global unit drug dose delivery system market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global unit drug dose delivery system market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global unit drug dose delivery system market.

The report delves into the competitive landscape of the global unit drug dose delivery system market. Key players operating in the global unit drug dose delivery system market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global unit drug dose delivery system market profiled in this report.

Key Questions Answered in Global unit drug dose delivery system Market Report:

  • What is the sales/revenue generated by unit drug dose delivery system across all regions during the forecast period?
  • What are the opportunities in the global unit drug dose delivery system market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2032?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Unit Drug Dose Delivery System Market - Research Objectives and Research Approach

The comprehensive report on the global unit drug dose delivery system market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global unit drug dose delivery system market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2032 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global unit drug dose delivery system market.

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. TMR Analysis and Recommendations

2. Market Viewpoint

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Unit Drug Dose Delivery System Market Overview

  • 3.1. Global Packaging Market Overview
  • 3.2. Macro-economic Factors - Correlation Analysis
  • 3.3. Forecast Factors - Relevance & Impact
  • 3.4. Unit Drug Dose Delivery System Market Value Chain Analysis
    • 3.4.1. Exhaustive List of Active Participants
      • 3.4.1.1. Raw Material Suppliers
      • 3.4.1.2. Manufactures
      • 3.4.1.3. Distributors/ End-users
    • 3.4.2. Profitability Margins
  • 3.5. Cased Based Scenario Impact Analysis
  • 3.6. Market Dynamics
    • 3.6.1. Drivers
    • 3.6.2. Restraints
    • 3.6.3. Opportunity Analysis
    • 3.6.4. Trends

4. Unit Drug Dose Delivery System Market Analysis

  • 4.1. Pricing Analysis
    • 4.1.1. Pricing Assumption
    • 4.1.2. Price Projections By Region
  • 4.2. Market Size (US$ Mn) and Forecast
    • 4.2.1. Market Size and Y-o-Y Growth
    • 4.2.2. Absolute $ Opportunity

5. Global Unit Drug Dose Delivery System Market Analysis and Forecast, By Material

  • 5.1. Introduction
    • 5.1.1. Market share and Basis Points (BPS) Analysis, By Material
    • 5.1.2. Y-o-Y Growth Projections, By Material
  • 5.2. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Material
  • 5.3. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Material
    • 5.3.1. Plastic
      • 5.3.1.1. Polypropylene (PP)
      • 5.3.1.2. Polyethylene (PE)
        • 5.3.1.2.1. HDPE
        • 5.3.1.2.2. LDPE
      • 5.3.1.3. Polyethylene Terephthalate (PET)
      • 5.3.1.4. Polyvinyl chloride (PVC)
      • 5.3.1.5. Polystyrene
      • 5.3.1.6. Polycarbonate
    • 5.3.2. Glass
      • 5.3.2.1. Type I
      • 5.3.2.2. Type II
      • 5.3.2.3. Type II
    • 5.3.3. Others
  • 5.4. Market Attractiveness Analysis, By Material

6. Global Unit Drug Dose Delivery System Market Analysis and Forecast, By Packaging Type

  • 6.1. Introduction
    • 6.1.1. Market share and Basis Points (BPS) Analysis, By Packaging Type
    • 6.1.2. Y-o-Y Growth Projections, By Packaging Type
  • 6.2. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Packaging Type
  • 6.3. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Packaging Type
    • 6.3.1. Blister Packaging
    • 6.3.2. Prefillable Syringes & Cartridges
    • 6.3.3. Vials & Ampoules
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, By Packaging Type
  • 6.5. Prominent Trends

7. Global Unit Drug Dose Delivery System Market Analysis and Forecast, By Product Form

  • 7.1. Introduction
    • 7.1.1. Market share and Basis Points (BPS) Analysis, By Product Form
    • 7.1.2. Y-o-Y Growth Projections, By Product Form
  • 7.2. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Product Form
  • 7.3. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Product Form
    • 7.3.1. Solid
    • 7.3.2. Liquid
    • 7.3.3. Powder
  • 7.4. Market Attractiveness Analysis, By Product Form

8. Global Unit Drug Dose Delivery System Market Analysis and Forecast, By Region

  • 8.1. Introduction
    • 8.1.1. Market share and Basis Points (BPS) Analysis By Region
    • 8.1.2. Y-o-Y Growth Projections By Region
  • 8.2. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Region
  • 8.3. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032 By Region
    • 8.3.1. North America
    • 8.3.2. Latin America
    • 8.3.3. Europe
    • 8.3.4. Asia Pacific
    • 8.3.5. Middle East & Africa (MEA)
  • 8.4. Market Attractiveness Analysis By Region
  • 8.5. Prominent Trends

9. North America Unit Drug Dose Delivery System Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Market share and Basis Points (BPS) Analysis, By Country
    • 9.1.2. Y-o-Y Growth Projections, By Country
  • 9.2. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Country
  • 9.3. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Country
    • 9.3.1. U.S.
    • 9.3.2. Canada
  • 9.4. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Material
  • 9.5. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Material
    • 9.5.1. Plastic
      • 9.5.1.1. Polypropylene (PP)
      • 9.5.1.2. Polyethylene (PE)
        • 9.5.1.2.1. HDPE
        • 9.5.1.2.2. LDPE
      • 9.5.1.3. Polyethylene Terephthalate (PET)
      • 9.5.1.4. Polyvinyl chloride (PVC)
      • 9.5.1.5. Polystyrene
      • 9.5.1.6. Polycarbonate
    • 9.5.2. Glass
      • 9.5.2.1. Type I
      • 9.5.2.2. Type II
      • 9.5.2.3. Type II
    • 9.5.3. Others
  • 9.6. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Packaging Type
  • 9.7. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Packaging Type
    • 9.7.1. Blister Packaging
    • 9.7.2. Prefillable Syringes & Cartridges
    • 9.7.3. Vials & Ampoules
    • 9.7.4. Others
  • 9.8. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Product Form
  • 9.9. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Product Form
    • 9.9.1. Solid
    • 9.9.2. Liquid
    • 9.9.3. Powder
  • 9.10. Prominent Trends
  • 9.11. Drivers and Restraints: Impact Analysis

10. Latin America Unit Drug Dose Delivery System Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Market share and Basis Points (BPS) Analysis, By Country
    • 10.1.2. Y-o-Y Growth Projections, By Country
  • 10.2. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Country
  • 10.3. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032 By Country
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Argentina
    • 10.3.4. Rest of Latin America
  • 10.4. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Material
  • 10.5. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Material
    • 10.5.1. Plastic
      • 10.5.1.1. Polypropylene (PP)
      • 10.5.1.2. Polyethylene (PE)
        • 10.5.1.2.1. HDPE
        • 10.5.1.2.2. LDPE
      • 10.5.1.3. Polyethylene Terephthalate (PET)
      • 10.5.1.4. Polyvinyl chloride (PVC)
      • 10.5.1.5. Polystyrene
      • 10.5.1.6. Polycarbonate
    • 10.5.2. Glass
      • 10.5.2.1. Type I
      • 10.5.2.2. Type II
      • 10.5.2.3. Type II
    • 10.5.3. Others
  • 10.6. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Packaging Type
  • 10.7. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Packaging Type
    • 10.7.1. Blister Packaging
    • 10.7.2. Prefillable Syringes & Cartridges
    • 10.7.3. Vials & Ampoules
    • 10.7.4. Others
  • 10.8. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Product Form
  • 10.9. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Product Form
    • 10.9.1. Solid
    • 10.9.2. Liquid
    • 10.9.3. Powder
  • 10.10. Prominent Trends
  • 10.11. Drivers and Restraints: Impact Analysis

11. Europe Unit Drug Dose Delivery System Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Market share and Basis Points (BPS) Analysis, By Country
    • 11.1.2. Y-o-Y Growth Projections, By Country
  • 11.2. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Country
  • 11.3. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032 By Country
    • 11.3.1. Germany
    • 11.3.2. Spain
    • 11.3.3. Italy
    • 11.3.4. France
    • 11.3.5. U.K.
    • 11.3.6. BENELUX
    • 11.3.7. Nordic
    • 11.3.8. Russia
    • 11.3.9. Poland
    • 11.3.10. Rest of Europe
  • 11.4. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Material
  • 11.5. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Material
    • 11.5.1. Plastic
      • 11.5.1.1. Polypropylene (PP)
      • 11.5.1.2. Polyethylene (PE)
        • 11.5.1.2.1. HDPE
        • 11.5.1.2.2. LDPE
      • 11.5.1.3. Polyethylene Terephthalate (PET)
      • 11.5.1.4. Polyvinyl chloride (PVC)
      • 11.5.1.5. Polystyrene
      • 11.5.1.6. Polycarbonate
    • 11.5.2. Glass
      • 11.5.2.1. Type I
      • 11.5.2.2. Type II
      • 11.5.2.3. Type II
    • 11.5.3. Others
  • 11.6. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Packaging Type
  • 11.7. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Packaging Type
    • 11.7.1. Blister Packaging
    • 11.7.2. Prefillable Syringes & Cartridges
    • 11.7.3. Vials & Ampoules
    • 11.7.4. Others
  • 11.8. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Product Form
  • 11.9. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Product Form
    • 11.9.1. Solid
    • 11.9.2. Liquid
    • 11.9.3. Powder
  • 11.10. Prominent Trends
  • 11.11. Drivers and Restraints: Impact Analysis

12. Asia Pacific Unit Drug Dose Delivery System Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Market share and Basis Points (BPS) Analysis, By Country
    • 12.1.2. Y-o-Y Growth Projections, By Country
  • 12.2. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Country
  • 12.3. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032 By Country
    • 12.3.1. China
    • 12.3.2. India
    • 12.3.3. Japan
    • 12.3.4. ASEAN
    • 12.3.5. Australia and New Zealand
    • 12.3.6. South Korea
    • 12.3.7. Rest of APAC
  • 12.4. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Material
  • 12.5. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Material
    • 12.5.1. Plastic
      • 12.5.1.1. Polypropylene (PP)
      • 12.5.1.2. Polyethylene (PE)
        • 12.5.1.2.1. HDPE
        • 12.5.1.2.2. LDPE
      • 12.5.1.3. Polyethylene Terephthalate (PET)
      • 12.5.1.4. Polyvinyl chloride (PVC)
      • 12.5.1.5. Polystyrene
      • 12.5.1.6. Polycarbonate
    • 12.5.2. Glass
      • 12.5.2.1. Type I
      • 12.5.2.2. Type II
      • 12.5.2.3. Type II
    • 12.5.3. Others
  • 12.6. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Packaging Type
  • 12.7. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Packaging Type
    • 12.7.1. Blister Packaging
    • 12.7.2. Prefillable Syringes & Cartridges
    • 12.7.3. Vials & Ampoules
    • 12.7.4. Others
  • 12.8. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Product Form
  • 12.9. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Product Form
    • 12.9.1. Solid
    • 12.9.2. Liquid
    • 12.9.3. Powder
  • 12.10. Prominent Trends
  • 12.11. Drivers and Restraints: Impact Analysis

13. Middle East and Africa Unit Drug Dose Delivery System Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Market share and Basis Points (BPS) Analysis, By Country
    • 13.1.2. Y-o-Y Growth Projections, By Country
  • 13.2. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Country
  • 13.3. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Country
    • 13.3.1. North Africa
    • 13.3.2. GCC countries
    • 13.3.3. South Africa
    • 13.3.4. Turkey
    • 13.3.5. Rest of MEA
  • 13.4. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Material
  • 13.5. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Material
    • 13.5.1. Plastic
      • 13.5.1.1. Polypropylene (PP)
      • 13.5.1.2. Polyethylene (PE)
        • 13.5.1.2.1. HDPE
        • 13.5.1.2.2. LDPE
      • 13.5.1.3. Polyethylene Terephthalate (PET)
      • 13.5.1.4. Polyvinyl chloride (PVC)
      • 13.5.1.5. Polystyrene
      • 13.5.1.6. Polycarbonate
    • 13.5.2. Glass
      • 13.5.2.1. Type I
      • 13.5.2.2. Type II
      • 13.5.2.3. Type II
    • 13.5.3. Others
  • 13.6. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Packaging Type
  • 13.7. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Packaging Type
    • 13.7.1. Blister Packaging
    • 13.7.2. Prefillable Syringes & Cartridges
    • 13.7.3. Vials & Ampoules
    • 13.7.4. Others
  • 13.8. Historical Market Value(US$ Mn) and Volume (Tons), 2018-2023, By Product Form
  • 13.9. Market Size (US$ Mn) and Volume (Tons) Forecast Analysis 2024-2032, By Product Form
    • 13.9.1. Solid
    • 13.9.2. Liquid
    • 13.9.3. Powder
  • 13.10. Prominent Trends
  • 13.11. Drivers and Restraints: Impact Analysis

14. Competitive Landscape

  • 14.1. Market Structure
  • 14.2. Competition Dashboard
  • 14.3. Company Market Share Analysis
  • 14.4. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments, SWOT analysis)
  • 14.5. Competition Deep Dive
    • 14.5.1. Amcor plc
      • 14.5.1.1. Overview
      • 14.5.1.2. Financials
      • 14.5.1.3. Strategy
      • 14.5.1.4. Recent Developments
      • 14.5.1.5. SWOT Analysis
    • 14.5.2. Wihuri Group
      • 14.5.2.1. Overview
      • 14.5.2.2. Financials
      • 14.5.2.3. Strategy
      • 14.5.2.4. Recent Developments
      • 14.5.2.5. SWOT Analysis
    • 14.5.3. Schott AG
      • 14.5.3.1. Overview
      • 14.5.3.2. Financials
      • 14.5.3.3. Strategy
      • 14.5.3.4. Recent Developments
      • 14.5.3.5. SWOT Analysis
    • 14.5.4. NIPRO
      • 14.5.4.1. Overview
      • 14.5.4.2. Financials
      • 14.5.4.3. Strategy
      • 14.5.4.4. Recent Developments
      • 14.5.4.5. SWOT Analysis
    • 14.5.5. Gerresheimer AG
      • 14.5.5.1. Overview
      • 14.5.5.2. Financials
      • 14.5.5.3. Strategy
      • 14.5.5.4. Recent Developments
      • 14.5.5.5. SWOT Analysis
    • 14.5.6. West Pharmaceutical Services, Inc.
      • 14.5.6.1. Overview
      • 14.5.6.2. Financials
      • 14.5.6.3. Strategy
      • 14.5.6.4. Recent Developments
      • 14.5.6.5. SWOT Analysis
    • 14.5.7. SGD Pharma
      • 14.5.7.1. Overview
      • 14.5.7.2. Financials
      • 14.5.7.3. Strategy
      • 14.5.7.4. Recent Developments
      • 14.5.7.5. SWOT Analysis
    • 14.5.8. R-Pharm Germany GmbH
      • 14.5.8.1. Overview
      • 14.5.8.2. Financials
      • 14.5.8.3. Strategy
      • 14.5.8.4. Recent Developments
      • 14.5.8.5. SWOT Analysis
    • 14.5.9. Agrado S.A.
      • 14.5.9.1. Overview
      • 14.5.9.2. Financials
      • 14.5.9.3. Strategy
      • 14.5.9.4. Recent Developments
      • 14.5.9.5. SWOT Analysis
    • 14.5.10. Constantia Flexibles
      • 14.5.10.1. Overview
      • 14.5.10.2. Financials
      • 14.5.10.3. Strategy
      • 14.5.10.4. Recent Developments
      • 14.5.10.5. SWOT Analysis
    • 14.5.11. Stevanato Group
      • 14.5.11.1. Overview
      • 14.5.11.2. Financials
      • 14.5.11.3. Strategy
      • 14.5.11.4. Recent Developments
      • 14.5.11.5. SWOT Analysis
    • 14.5.12. Klockner Pentaplast
      • 14.5.12.1. Overview
      • 14.5.12.2. Financials
      • 14.5.12.3. Strategy
      • 14.5.12.4. Recent Developments
      • 14.5.12.5. SWOT Analysis
    • 14.5.13. Catalent, Inc.
      • 14.5.13.1. Overview
      • 14.5.13.2. Financials
      • 14.5.13.3. Strategy
      • 14.5.13.4. Recent Developments
      • 14.5.13.5. SWOT Analysis
    • 14.5.14. Huhtamaki Oyj
      • 14.5.14.1. Overview
      • 14.5.14.2. Financials
      • 14.5.14.3. Strategy
      • 14.5.14.4. Recent Developments
      • 14.5.14.5. SWOT Analysis
    • 14.5.15. Omnicell, Inc.
      • 14.5.15.1. Overview
      • 14.5.15.2. Financials
      • 14.5.15.3. Strategy
      • 14.5.15.4. Recent Developments
      • 14.5.15.5. SWOT Analysis
    • 14.5.16. Piramal Enterprises Ltd.
      • 14.5.16.1. Overview
      • 14.5.16.2. Financials
      • 14.5.16.3. Strategy
      • 14.5.16.4. Recent Developments
      • 14.5.16.5. SWOT Analysis
    • 14.5.17. O. Berk Company
      • 14.5.17.1. Overview
      • 14.5.17.2. Financials
      • 14.5.17.3. Strategy
      • 14.5.17.4. Recent Developments
      • 14.5.17.5. SWOT Analysis

15. Assumptions and Acronyms Used

16. Research Methodology

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦